Hormetic Stress Biohacking Type 1 Diabetes CGM

-
Image
Photo: Unsplash.com Medical Disclaimer : The content on this blog is purely for informational purposes only. For medical advice, diagnosis and treatment, consult your doctor. The ultimate goal for anyone living with Type 1 Diabetes (T1D) is stability. You want fewer spikes, fewer crashes, and more time spent in your target blood sugar range. Read more on blood sugar spike . For years, standard medical advice focused purely on matching insulin doses to carbohydrate intake. While this foundational math is necessary, it often leaves people riding a frustrating blood sugar roller coaster. Today, a new wave of tech-savvy individuals is looking beyond the traditional playbook. They are combining the principles of biohacking, the physiological benefits of hormetic stress, and the real-time data of Continuous Glucose Monitors (CGMs) to transform how they manage their health. This approach does not replace insulin. Instead, it aims to make the body more resilient, predictable, and res...
Post a Comment

Chemistry, Manufacturing and Control (CMC) Flexibility for Cell and Gene Therapies

-
The U.S. Food and Drug Administration (FDA) has announced it is sharing information about the agency's flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).

The agency's more flexible approach has been, and is expected to continue to be helpful in expediting product development and will help guide the FDA's evaluation of development of strategies in preparation for a Biologics License Application (BLA) submission, said FDA.


"Regulatory flexiblity must be tailored for cell and gene therapies," said FDA Commissioner Marty Makary, M.D., M.P.H.  "These are common sense reforms that will address the unique characteristics of cell and gene therapies and foster more innovation."

Over the last decade, the agency said, the FDA's Center for Biologics Evaluation and Research (CBER) has approved close to 50 CGTs. The transformative potential of these therapies has captured the imagination of the patient community and ignited product development.

"There has been tremendous enthusiasm amongst product developers resulting in an explosive growth of cell and gene therapy submissions, many of which target serious life-threatening conditions with unmet medical needs," said Vinay Prasad, M.D., M.P.H., Chief Medical and Scientific Officer and Director of the FDA's Center for Biologics Evaluation and Research. "CBER is eager for stakeholders to know that our effectiveness at exercising greater regulatory flexibility around chemistry, manufacturing and control requirements furthers innovative product development."

CBER has historically had similar CMC expectations across products, including small-batch products such as CGTs. CGTs are inherently complex biologic products, often individualized for patients, and may need sophisticated manufacturing under particular time constraints, said FDA.

CBER has leveraged its growing experience with CGT products to identify and implement regulatory flexibilities allowed under FDA's regulations that accommodate the unique characteristics of these innovation therapies, while maintaining rigorous quality standards through appropriate control measures, said FDA.

While there is a long history of making concerted efforts to help sponsors meet standards to assure product safety, purity and potency, the application of flexibilities has not always been fully clear to stakeholders.

"CBER is proactively communicating about regulatory flexibilities that were previously applied case-by-case to select CGT therapies. By communicating these approaches broadly, we aim to expedite product development across the CGT field," said Vijay Kumar M.D., Acting Director, Office of Therapeutic Products in the FDA's Center for Biologics Evaluation and Research.

"It is vital that every sponsor, no matter the CBER reviewer team they engage with, understand what types of regulatory flexibility may be scientifically acceptable."

Comments

Post a Comment


Popular posts from this blog

The Impressive Health Benefits of Pumpkin Seeds

-
Image
S  Eating pumpkin seeds may reduce risks of breast and prostate cancer s Pumpkin seeds, often discarded as waste, are a nutritional powerhouse packed with vitamins, minerals, and antioxidants. These tiny seeds have been used for centuries in traditional medicine , and modern research confirms their impressive health benefits.  Let's discuss the reasons why you should add pumpkin seeds to your diet. 1. Rich in Nutrients Pumpkin seeds are a rich source of protein, healthy fats, fiber, and essential minerals like magnesium, zinc, and iron . One ounce (28g) provides 9g of protein, 14g of fat, and 1.7mg of iron [1]. 2. Supports Prostate Health The high zinc content in pumpkin seeds may help alleviate symptoms of benign prostatic hyperplasia (BPH) and support prostate health. 3. Promotes Heart Health Pumpkin seeds are rich in antioxidants, magnesium, and healthy fats, which can help lower blood pressure, cholesterol, and triglycerides, reducing cardiovascular risk [2]. 4. Reg...
Read more

The Grave Consequences of Attacking Health Sites in Iran

-
Image
War distrupts public health system, leaving especially women and children utterly devastated The attacks on health sites in Iran have severe consequences, affecting not only the country's healthcare system but also global cybersecurity. The World Health Organization (WHO) has verified 13 attacks on healthcare infrastructure in Iran , resulting in four healthcare worker fatalities and 25 injuries. These attacks have also disrupted medical services, putting patients' lives at risk. The humanitarian implications of these attacks are dire. Hospitals are being evacuated, and patients are being forced to seek alternative care . The WHO has expressed concern over the safety of healthcare workers and patients, emphasizing the need for protection of medical facilities and personnel. The conflict has also spawned a surge in cyberattacks , with Iranian-linked hacktivist groups targeting healthcare organizations worldwide. These attacks aim to disrupt services, steal sensitive data, and...
Read more

Why Gastric Ulcer Patients Should Avoid Tomatoes and Tomato-Based Products

-
Image
Gastric ulcer patients should avoid or limit tomatoes While nutritious, tomatoes are acidic and can irritate the stomach lining , exacerbating ulcer symptoms .  We present why ulcer patients generally and gastric ulcer patients particularly  should limit or avoid tomatoes and tomato-based products . The reasons are as follows: High Acidity Tomatoes are acidic (pH 4.1-4.6), which can irritate the stomach lining and worsen ulcer symptoms. Increased Acid Production Acidic foods like tomatoes can stimulate gastric acid secretion , increasing discomfort. Mucosal Irritation Tomato acidity can damage the mucosal lining, exacerbating ulcers and slowing healing. Pain and Discomfort Acidic tomatoes can cause heartburn , epigastric pain , and discomfort in ulcer patients. Delayed Healing Chronic irritation from tomatoes may slow down the healing process of ulcers. Lycopene While beneficial, lycopene 's acidity can irritate ulcers; cooking tomatoes may help reduce this effect. ...
Read more